Step Therapy (Fail First)

How It Works

Step therapy, also called fail-first protocols, typically requires documented trial-and-failure or intolerance on one to three first-line drugs before coverage of a more expensive second-line option. A classic example: rheumatoid arthritis patients must try methotrexate (an inexpensive oral DMARD, often under $30/month) before the plan covers a biologic like Humira or Enbrel (roughly $6,000/month list). For migraines, step therapy often requires trying beta blockers, topiramate, or amitriptyline before the plan covers CGRP-inhibitor injectables like Aimovig, Emgality, or Ajovy. Medicare Advantage plans gained authority to impose step therapy on Part B drugs in 2019 under a controversial CMS policy change. Forty-one states and DC have enacted step therapy reform laws requiring exceptions when the prescriber certifies medical reasons, such as prior trial on similar drugs, documented contraindication, or stable current therapy. The American College of Rheumatology, American Academy of Neurology, and most specialty societies oppose step therapy for serious autoimmune and neurological conditions. Step therapy can be stacked with prior authorization, patients sometimes need to document two or three drug failures and then submit a PA with extensive clinical support. The CMS Medicare Advantage 2025 rule tightened step-therapy application to require equivalent clinical criteria across the network and to count prior trials that occurred under a different insurer.

Related Terms

• Prior Authorization, A requirement by an insurer that a patient's doctor must get approval before the plan will cover a specific drug, used to control costs and ensure appropriate use.
• Formulary, A list of prescription drugs covered by an insurance plan, organized into tiers that determine how much the patient pays for each drug.
• Specialty Drug, A high-cost medication, typically above $1,000 per month, that treats complex or chronic conditions and often requires special handling, storage, or administration.